131I-MIBG - Fujifilm RI Pharma

Drug Profile

131I-MIBG - Fujifilm RI Pharma

Alternative Names: 131I-MIBG - Fujifilm Pharma; I-131 3-iodobenzylguanidine

Latest Information Update: 02 Feb 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator FUJIFILM RI Pharma
  • Class Antineoplastics; Iodobenzenes; Radiopharmaceuticals; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Neuroblastoma

Most Recent Events

  • 30 Nov 2016 Fujifilm Pharma plans to initiate a clinical trial in Neuroblastoma in Japan (UMIN000025045)
  • 29 Nov 2016 Preclinical trials in Neuroblastoma in Japan (unspecified route) (UMIN000025045)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top